Brazilian researchers from the journals “Biochimie” and “Biochemical and Biophysical Research Communications” report on two new peptides with biotechnological potential found in snake venom. This discovery opens up new perspectives in the fields of medicine and pharmacology.
The venom of the South American silent rattlesnake, which reaches a length of over 4 meters, is known for its powerful dose of venom. Although it is not particularly lethal to humans, this snake injects it in large quantities to compensate for the lack of a rattling warning on its tail. In addition to the silent rattlesnake, scientists have also discovered new peptides with biotechnological potential in the venom of the lancehead viper, which inhabits southern Brazil.
These new peptides represent a promising resource for future research and drug development. Peptides are short chains of amino acids that can have diverse functions in organisms. The identified peptides from snake venom may have biotechnological potential that can be utilized to develop new drugs for various diseases.
Research on snake venom is of great importance to medicine and pharmacology. Snake venom contains many biologically active substances that may have medicinal properties. Examples of toxins from snake venom that are used in medicine include analgesics and anti-inflammatory drugs.
Thanks to the discovery of these two new peptides in snake venom, scientists now have another step forward in the research of potential biotechnological drugs. This new knowledge opens up prospects for future therapies and treatments for various diseases.
FAQ
The source of the article is from the blog exofeed.nl